Iris Löw-Friedrich - Articles and news items

Amgen logo

Romosozumab Phase 2 data published In New England Journal Of Medicine show significant increases in bone mineral density at both spine and hip

Industry news / 1 January 2014 / Amgen

“The results of the study demonstrate significantly increased BMD and stimulation of bone formation with romosozumab treatment…”

Could a ‘super computer’ help improve epilepsy care? Yes, it’s elementary my dear WATSON

Industry news, News / 16 May 2013 / UCB

UCB and IBM have announced the completion of the initial phase of a pioneering project…

Amgen logo

UCB and Amgen initiate sclerostin antibody Phase 3 program in patients with Postmenopausal Osteoporosis

Industry news, News / 4 April 2012 / Amgen

The start of sclerostin antibody Phase 3 clinical trial program announced…

Amgen logo

Amgen and UCB team up With NASA

Industry news, News / 5 July 2011 / Amgen

Amgen and UCB announced that they are collaborating with the NASA Ames Research Center to conduct a preclinical test…

Amgen logo

Amgen and UCB announce positive phase 2 results of AMG 785/CDP7851 in Patients With PMO

Industry news, News / 21 April 2011 / Amgen

Amgen & UCB announced positive top-line results from their Phase 2 clinical study…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...